Food Reward Processing in the Human Brain

March 28, 2022 updated by: Joe Simon, University of Heidelberg Medical Center

Integration of Homeostatic Signaling and Food Reward Processing in the Human Brain

The aim of this study is to investigate the influence of different metabolic states and hormonal satiety signalling on responses in neural reward networks.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Given the rapid development of obesity world-wide, a better understanding of the interaction between the encoding of food reward in mesocorticolimbic reward pathways and homeostatic energy regulation is of paramount importance for the development of new treatment strategies. Healthy participants will undergo functional magnetic resonance imaging while performing a task distinguishing between the anticipation and the receipt of either food or monetary reward. Every participant will be scanned twice in a counterbalanced fashion, both during a state of hunger (after 24-hours fasting) and satiety. Blood samples will be collected to assess hormonal satiety signalling. We hope to provide new insights into the neurobiological underpinnings of motivational processing and hedonic evaluation of food reward.

Study Type

Observational

Enrollment (Actual)

23

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Healthy normal weight female participants

Description

Inclusion Criteria:

  • BMI <25 kg/m² and >18.5 kg/m²
  • no lifetime or current medical illness that could potentially affect appetite or body weight
  • right-handedness
  • normal or corrected-to-normal vision

Exclusion Criteria:

  • history of head injury or surgery
  • history of neurological disorder
  • severe psychiatric disorder (psychosis, bipolar disorder, substance abuse)
  • smoking
  • borderline personality disorder
  • current psychotropic medication
  • inability to undergo fMRI scanning (e.g. metallic implants, claustrophobia, Pacemakers)
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy Controls
Normal weight, healthy female participants
Participants were scanned twice: once after a meal and once after fasting for 24 hours

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experimental fMRI task (incentive delay task)
Time Frame: 22 min.
Participants were expecting food and monetary related reward, after a correct response to a simple task they received either food or monetary related reward.
22 min.
Resting state brain activity using functional magnetic resonance imaging
Time Frame: 5 min.
Functional brain imaging will be employed to assess functional connectivity in reward related brain networks.
5 min.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analysis of hormonal satiety signaling
Time Frame: 30 min. before scanning
Blood is collected for the measurement of peripheral ghrelin. One blood sample at the start of the experiment will be collected.
30 min. before scanning
Self-report questionnaire regarding eating behavior (Dutch Eating Behavior Questionnaire)
Time Frame: 30 min.
Psychometric tests will be employed to assess eating behavior and eating disorder psychopathology (using the Dutch Eating Behavior Questionnaire).
30 min.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joe Simon, Dr. Dipl. Psych., University Hospital Heidelberg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 9, 2015

Primary Completion (Actual)

June 10, 2016

Study Completion (Actual)

June 10, 2016

Study Registration Dates

First Submitted

March 10, 2017

First Submitted That Met QC Criteria

March 15, 2017

First Posted (Actual)

March 16, 2017

Study Record Updates

Last Update Posted (Actual)

March 29, 2022

Last Update Submitted That Met QC Criteria

March 28, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Satiety State

3
Subscribe